We are excited to welcome Bob Smith to the ATiO Foundation Advisory Board. With over 35 years of experience in gene therapy, rare diseases, and biopharmaceutical leadership, Smith brings invaluable expertise to ATiO’s mission of advancing regenerative and orthopaedic therapies.

ZuriMed has won the ATiO Early-Stage Pitch Contest at the ATiO Conference 2024 with their innovative Surgical FibreLock Technology. This groundbreaking technology offers new possibilities in surgery and impressed the audience with its efficiency and precision. The victory highlights ZuriMed's position as an uprising company in the medical technology field. Find out more!

The ATiO Foundation is proud to welcome Emil Billbäck to its Advisory Board. With over 25 years of international leadership in life sciences and regenerative medicine, Billbäck brings strategic insight and global experience that will support ATiO’s mission to advance orthopaedic innovation and global collaboration.

Discover the vibrant energy and memorable moments of the ATiO Conference 2024.  Our gallery offers a visual journey through the conference, highlighting the key moments and the people who made them happen. Whether you attended in person or are catching up from afar, these photographs provide a rich, colorful recap of an inspiring gathering.

Congratulations to Liposphere Ltd. for emerging as the victorious company among a pool of 14 exceptionally promising contenders in the Early-Stage-Company-Contest at the ATiO Conference 2023!

There are two general types of medical ultrasound: diagnostic and therapeutic. Diagnostic ultrasound is widely used to produce real-time images of the body, including for the determination of musculoskeletal injuries and follow-up of musculoskeletal interventions. Contrastingly, therapeutic ultrasound produces bioeffects within the body, via the direct or indirect interaction of acoustic waves with cells/tissue, with the goal of benefiting patient health.